皮肤头颈部黑色素瘤的病例量区域化及基于量的结局差异
基于2004-2016年美国国家癌症数据库556 079例皮肤黑色素瘤病例,将头颈部与非头颈部病例分开并按机构病例量分类。头颈部黑色素瘤中仅41家机构(3.1%)为高量机构,低量、中量、高量机构的5年总生存率分别为62.7%、69.3%、71.8%(p<0.001),校正混杂因素后高量机构与低量机构间总生存差异仍显著。结论认为病例量与头颈部黑色素瘤的总生存和手术结局独立相关。
要点
- 头颈部黑色素瘤中仅41家机构(3.1%)为高量机构。
- 低量、中量、高量机构5年总生存率分别为62.7%、69.3%、71.8%(p<0.001)。
- 校正混杂因素后,高量机构与低量机构间总生存差异仍显著。
核心结论
- 病例量与头颈部黑色素瘤的总生存和手术结局独立相关。
研究设计与样本
- 回顾性分析2004-2016年美国国家癌症数据库报告的556 079例皮肤黑色素瘤病例,分为头颈部与非头颈部两个队列,各队列内机构按病例量分类,采用卡方检验、方差分析、Kaplan-Meier法和Cox比例风险模型进行分析。
主要发现
- 头颈部黑色素瘤中仅41家机构(1326家中的3.1%)为高量机构,非头颈部黑色素瘤中仅50家机构(1344家中的3.7%)为高量机构。
- 头颈部黑色素瘤患者低量机构5年总生存率为62.7%(标准误0.4%),中量机构为69.3%(标准误0.4%),高量机构为71.8%(标准误0.4%)(p<0.001)。
- 校正混杂因素后,高量机构与低量机构间总生存差异仍显著。
关键数值与推荐
- 头颈部黑色素瘤低量机构5年总生存率62.7%(标准误0.4%),中量机构69.3%(标准误0.4%),高量机构71.8%(标准误0.4%)(p<0.001)。
- 头颈部黑色素瘤高量机构41家(1326家中的3.1%),非头颈部高量机构50家(1344家中的3.7%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hospital volume has emerged as a prognostic factor in oncology but is not currently known whether volume is associated with improved outcomes for cutaneous head and neck (HN) melanoma. METHODS: A total of 556 079 cutaneous melanoma cases reported by the 2004-2016 National Cancer Database were separated into two cohorts (HN and non-HN) and facilities within each cohort were classified by case volume. Analysis employed chi-square, analysis of variance, Kaplan-Meier, and Cox proportional hazards models. RESULTS: Only 41 facilities (3.1% of 1326) treating HN melanoma and 50 facilities (3.7% of 1344) treating non-HN melanoma were classified as high-volume facilities (HVFs). The estimated 5-year overall survival (OS) was 62.7% (standard error [SE]: 0.4%) for patients with HN at low-volume facilities (LVFs), 69.3% (SE: 0.4%) at IVFs, and 71.8% (SE 0.4%) at HVFs (p < 0.001). Differences in OS remained significant between HVFs versus LVFs after adjusting for confounders. CONCLUSION: Volume is independently associated with OS and improved surgical outcomes for HN melanoma.
引用
- Roman KM, Torabi SJ, Goshtasbi K, et al. Case volume regionalization and volume-based outcome differences in cutaneous head and neck melanoma. Head Neck. 2022. PMID: 35903986. doi:10.1002/hed.27150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。